Our vision is bold but well within reach. We invite you, as eye care professionals, to help us save the eyesight of millions by making early functional testing for AMD a routine part of eye care for your aging patients.
AdaptDx®, our scientifically validated, FDA 510(k)-cleared instrument enables subclinical detection of AMD through an easy-to-use functional test that accurately measures dark adaption. Dark adaptation is the only biomarker of AMD, and allows eye care professionals to detect AMD three years before drusen are visible. Early detection means preventive measures can begin sooner, eliminating unnecessary blindness.